Cerebras Systems (NASDAQ:CBRS – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Sunday.
A number of other research analysts also recently issued reports on the company. Morgan Stanley began coverage on Cerebras Systems in a research note on Monday, June 8th. They set an “overweight” rating and a $250.00 price objective for the company. Barclays initiated coverage on shares of Cerebras Systems in a research note on Monday, June 8th. They set an “overweight” rating and a $280.00 target price on the stock. Citigroup assumed coverage on shares of Cerebras Systems in a report on Monday, June 8th. They set a “buy” rating and a $340.00 price target on the stock. Needham & Company LLC assumed coverage on shares of Cerebras Systems in a research report on Monday, June 8th. They issued a “buy” rating and a $300.00 price target for the company. Finally, Mizuho began coverage on shares of Cerebras Systems in a research note on Monday, June 8th. They issued an “outperform” rating and a $300.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Cerebras Systems has an average rating of “Buy” and a consensus target price of $294.00.
View Our Latest Report on Cerebras Systems
Cerebras Systems Price Performance
About Cerebras Systems
Cerebras Systems is a technology company focused on building artificial intelligence infrastructure, including hardware and software designed to accelerate deep learning and large-scale AI workloads. The company is best known for its wafer-scale processor architecture, which is intended to provide high-performance compute for training and inference applications.
In addition to its AI chips, Cerebras offers systems and related software tools that support researchers and enterprises working with machine learning models.
See Also
- Five stocks we like better than Cerebras Systems
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Cerebras Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerebras Systems and related companies with MarketBeat.com's FREE daily email newsletter.
